Ultra-Sensitive MRD Utilization to Overcome Challenges in Early-Stage Cancer Recurrence Detection
Time: 3:00 pm
day: Day One Track B (1)
Details:
- NeXT Personal is an advanced tumor-informed liquid biopsy assay with ultra-sensitive detection down to 1PPM
- Ultrasensitive detection with this bespoke whole genome sequencing based assay improves detection of ctDNA at baseline and during follow-up with increased lead time over clinical relapse
- Clinical studies in early-stage lung and breast cancer establish that NeXT Personal MRD detection is strongly correlated with patient outcome
